Mizuno, Tomoyuki http://orcid.org/0000-0002-8471-9826
McPhail, Brooks T.
Kamatkar, Suyog
Wexelblatt, Scott
Ward, Laura
Christians, Uwe
Akinbi, Henry T.
Vinks, Alexander A.
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (5T32HD069054)
Article History
First Online: 17 September 2020
Declarations
:
: Brooks T. McPhail was supported by a Eunice Kennedy Shriver National Institute of Child Health and Human Development training Grant (5T32HD069054).
: Scott Wexelblatt has received a research grant from Chiesi Pharmaceuticals and a consulting fee from Braeburn Pharmaceuticals. He is also on a speaker bureau to discuss treatment options for NOWS. These payments had no effect on this paper or results. Tomoyuki Mizuno, Brooks T. McPhail, Suyog Kamatkar, Laura Ward, Uwe Christians, Henry T. Akinbi, and Alexander A. Vinks have no conflicts of interest that are directly relevant to the content of this article.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: Not applicable.
: Not applicable.
: TM, BTM, SK, SW, LW, UC, HTA, and AAV wrote the manuscript and designed the research. TM, BTM, SK, LW, UC, HTA, and AAV performed the research and analyzed the data.